Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
By preserving crucial NAD+ levels, it encourages your body to burn stored fat for fuel
It is a humane duty that we properly dispose of our injection waste
Coenzyme cellular energy IV/SubQ 100500 mg Mitochondrial-derived peptide preclinical 35x weekly 510 mg Mitochondrial-derived peptide preclinical no approved human dose Mitochondria-targeting peptide FDA-approved only for Barth syndrome daily 440 mg AEDG tetrapeptide bioregulator research-use 1020 day cycles Senolytic peptide preclinical only no validated human dose Endogenous antioxidant oral/liposomal/IV context 2501,000 mg oral study range MC receptor agonist preclinical loading + maintenance 250500 mcg Also listed under Repair skin remodeling topical/SubQ 12 mg Sexual Health & Hormonal Peptides studied for sexual response and hormonal pathways
Do not use a cracked vial
We are not yet offering AOD 9604 to patients
WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
US$ 24.83
US$ 25.77
US$ 27.60
US$ 25.43